INTEL//MAPGLOBAL OSINT WATCH ← Back to live monitor
LANG · RAW
humanitarian

Human medicines European public assessment report (EPAR): Qezzaqar, catequentinib, Status: Opinion

Human medicines European public assessment report (EPAR): Jylamvo, methotrexate, Date of authorisation: 29/03/2017, Revision: 16, Status: Authorised

Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

2 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Qezzaqar, catequentinib, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Qezzaqar, catequentinib, Status: Opinion
INCIDENT EVOLUTION

3 recorded states

Signal first indexedP2 · 99% quality · 2 sources

Headline updatedP2 · 99% quality · 2 sources

Source details updatedP2 · 99% quality · 2 sources

Explore this day in the archive →
Related intelligence

More in humanitarian

PRNEWSWIRE.COM · 08:30 UTC

Epilepsygtx and viralgen collaborate to advance aav gene therapy programme for epilepsy ahead of first in human trial

Open brief → AZERNEWS.AZ · 08:30 UTC

Baku and Asian Development Bank — Aid or support

Open brief → SB.BY · 08:30 UTC

Belarus will provide humanitarian aid to venezuela

Open brief → TRADEARABIA.COM · 08:30 UTC

Egypt’s first AI factory to be set up by Vodafone Cassava

Open brief →
QUALITY CONTROL

Report this signal

Reports are anonymous and retained privately for editorial review.